AI reads skin scars to pick best cancer treatment

NCT ID NCT05856565

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to develop an artificial intelligence (AI) algorithm that analyzes skin damage (dermatoheliosis) around a melanoma scar to predict whether a patient will respond to anti-PD-1 immunotherapy. Researchers will collect photos and medical data from 700 adults with advanced skin cancer. The goal is to create a simple, non-invasive tool to help doctors choose the most effective treatment for each patient.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ambroise Paré Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

  • Angers University Hospital

    RECRUITING

    Angers, Maine-et-Loire, 49000, France

  • Avicenne Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

  • Besancon University Hospital

    RECRUITING

    Besançon, Bourgogne-Franche-Comté, 25000, France

  • Bichat Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

  • Blois Hospital site

    NOT_YET_RECRUITING

    Blois, France

  • Bordeaux University Hospital

    NOT_YET_RECRUITING

    Bordeaux, France

  • Brest University Hospital

    RECRUITING

    Brest, Finistère, 29000, France

  • CH du Mans

    NOT_YET_RECRUITING

    Le Mans, France

  • CHU de La Rochelle

    NOT_YET_RECRUITING

    La Rochelle, France

  • CHU de Rennes

    NOT_YET_RECRUITING

    Rennes, France

  • Dijon University Hospital

    NOT_YET_RECRUITING

    Dijon, France

  • Eugène Marquis site - Rennes

    NOT_YET_RECRUITING

    Rennes, France

  • Grenoble University Hospital

    NOT_YET_RECRUITING

    Grenoble, France

  • ICO

    NOT_YET_RECRUITING

    Saint-Herblain, France

  • Léon Site Bérard in Lyon

    NOT_YET_RECRUITING

    Lyon, France

  • Nantes University Hospital

    RECRUITING

    Nantes, France

  • Rouen University Hospital

    NOT_YET_RECRUITING

    Rouen, France

  • Saint-Louis Hospital - APHP

    NOT_YET_RECRUITING

    Paris, France

  • Valence Hospital Site

    NOT_YET_RECRUITING

    Valence, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.